Jovan Antovic

Jovan P. Antovic is a Professor and Chief Physician at the Clinical Chemistry and Coagulation research group, Department of Molecular Medicine and Surgery, Karolinska Institutet. He combines clinical practice as a senior physician at Karolinska University Laboratory with academic leadership, while maintaining visiting professorships at University of Niš and University of Kragujevac (Serbia). His work bridges internal medicine, hematology, and clinical chemistry expertise acquired through 2003 PhD from KI and 2011 specialist certification.

• Education: MD (1993, University of Niš), PhD (2003, Karolinska Institutet)
• Certifications: Internal Medicine Specialist (1998), Clinical Chemistry Specialist (2011)

Research focuses on hemostasis and thrombosis, particularly in hemophilia patients and those with prothrombotic conditions. Key innovations include evaluating global hemostatic methods (thrombin generation, overall hemostatic potential) as diagnostic tools and studying microparticle biology in bleeding/thrombotic disorders. Current projects investigate aging-related thrombotic risk in hemophilia, liver disease coagulopathy, and rheumatological thrombosis mechanisms.

Recent publications demonstrate trends across hemophilia management, anticoagulant monitoring, and COVID-19 coagulopathy. His team has developed microparticle analysis techniques, refined VWF testing, and explored complement system interactions in thrombosis. While not explicitly listed, his leadership in translational hemostasis research suggests numerous institutional and international collaborations.

Clinical leadership includes KARMITH Core Facility development and mentorship of PhD candidates Maria Farm and Yanan Zong. The group maintains active partnerships with Serbian institutions and participates in multi-center clinical trial networks, particularly in thrombosis diagnostics and anticoagulant therapy optimization.